AstraZeneca AZN
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
AstraZeneca (AZN) Business Model and Operations Summary
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
Key Insights
AstraZeneca (AZN) Core Market Data and Business Metrics
Latest Closing Price
$72.6Market Cap
$224.90 BillionTotal Outstanding Shares
1.55 Billion SharesTotal Employees
94,300Dividend
$1.05 Per Share BiannuallyIPO Date
May 18, 1993Primary Exchange
NASDAQ
Historical Stock Splits
If you bought 1 share of AZN before July 27, 2015, you'd have 2 shares today.
Execution Date | Split Amount |
---|---|
July 27, 2015 | 2-for-1 |
Historical Dividends
Current dividend: $1.05 Per Share Biannually
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Feb 6, 2025 | Mar 24, 2025 | Feb 21, 2025 | $1.05 | Biannually |
Jul 25, 2024 | Sep 9, 2024 | Aug 9, 2024 | $0.5 | Biannually |
Feb 8, 2024 | Mar 25, 2024 | Feb 23, 2024 | $0.985 | Biannually |
Jul 28, 2023 | Sep 11, 2023 | Aug 11, 2023 | $0.465 | Biannually |
Feb 9, 2023 | Mar 27, 2023 | Feb 24, 2023 | $0.985 | Biannually |
Feb 10, 2022 | Mar 28, 2022 | Feb 25, 2022 | $0.985 | Biannually |